Rubinstein Linda M
SEC insider (Form 3/4/5 filer). CIK 0001321937. Interim CFO at NEKTAR THERAPEUTICS (NKTR) and 1 other issuer. 13 reported Form 4/5 transactions since Sep 2024; latest on Dec 9, 2025. Located in SAN FRANCISCO, CA.
Companies Rubinstein Linda M has filed insider reports for
- NEKTAR THERAPEUTICS (NKTR): Officer, Interim CFO
- Adverum Biotechnologies, Inc. (ADVM): Officer, CHIEF FINANCIAL OFFICER
Rubinstein Linda M
CIK: 0001321937
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
ExerciseDirect48.8K shares at avg. $4.20$205K - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
Tender OfferDirect61.2K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
Tender OfferDirect8.1K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
AwardDirect42K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
Tender OfferDirect42K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
35K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
85K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
62.1K shares- - Jun 17, 2025ADVM
Adverum Biotechnologies, Inc.
AwardDirectStock Option (Right to Buy)
35K shares- - Jun 17, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
85K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 9, 2025 |  ADVM Adverum Biotechnologies, Inc. | Exercise | 48,750 | $4.20 | $204,750 | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Tender Offer | 61,150 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Tender Offer | 8,125 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Award | 42,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Tender Offer | 42,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 35,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 85,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 62,083 | - | - | Direct |
| Jun 17, 2025 | ADVM Adverum Biotechnologies, Inc. | Award Stock Option (Right to Buy) | 35,000 | - | - | Direct |
| Jun 17, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 85,000 | - | - | Direct |
1-10 of 13 transactions